Emtricitabine: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/959998/Cv/2'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/959998/Cv/2'> | ||
Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine | Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children. See also [https://en.wikipedia.org/wiki/Emtricitabine Emtricitabine]. | ||
Emtricitabine is also marketed in a fixed-dose combination with [[tenofovir disoproxil]] (Viread) under the brand name Truvada, and with tenofovir alafenamide (Vemlidy) under the brand name Descovy. | Emtricitabine is also marketed in a fixed-dose combination with [[tenofovir disoproxil]] (Viread) under the brand name Truvada, and with tenofovir alafenamide (Vemlidy) under the brand name Descovy. | ||
